Skip to content

Comprehensive Genomic Tumor Profiling

The Illumina Genomics Podcast

Comprehensive Genomic Tumor Profiling

Dec 11, 2019 | Episode 57 | 20 mins

NGS-based genomics assays can help characterize the genetic profile of a tumor, and these technologies are poised to supplant single-gene testing in oncology. But, what impact will this revolutionary technology have on patients, clinicians, and the entire healthcare system? Listen to Dr. Brian Piening of the Providence Cancer Institute explain how NGS is changing the standard of care in oncology.

Download or subscribe to our recurring podcasts.